Related Experiment Video

Updated: Jul 11, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications

Giuseppina Basta1

  • 1CNR, Institute of Clinical Physiology, San Cataldo Research Area, Via Moruzzi 1, 56124 Pisa, Italy.

Atherosclerosis
|September 11, 2007
PubMed

Insights

The receptor for advanced glycation endproducts (RAGE) and its ligands drive vascular disease, particularly in diabetes. Soluble RAGE (sRAGE) may act as a decoy, offering therapeutic potential for vascular inflammation.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • The receptor for advanced glycation endproducts (RAGE) is an immunoglobulin superfamily member with diverse ligands.
  • RAGE ligands, including glycoxidation products, S100 proteins, and amphoterin, are implicated in vascular disease pathogenesis.

Purpose of the Study:

  • To investigate the role of the RAGE-ligand axis in atherogenesis and vascular inflammation.
  • To explore the potential of soluble RAGE (sRAGE) as a therapeutic target.

Main Methods:

  • Review of existing literature on RAGE, its ligands, and their role in vascular disease.
  • Analysis of the mechanisms by which RAGE-ligand interactions modulate cellular activation and atherogenesis.

Main Results:

  • RAGE-ligand interactions promote an inflammatory-proliferative process in atherosclerosis, especially in diabetes.
  • Soluble RAGE (sRAGE) acts as a decoy receptor, potentially neutralizing circulating ligands.
  • The RAGE-ligand axis is critical in chronic vascular inflammation.

Conclusions:

  • The RAGE-ligand axis is a key driver of vascular disease and inflammation.
  • Targeting the RAGE-ligand pathway, potentially using sRAGE, offers a promising therapeutic strategy for limiting vascular damage.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...